ENZ

Enzo Biochem
NYSE

Real-time Quotes | Nasdaq Last Sale

2.100
+0.040
+1.94%
Closed 16:00 10/23 EDT
OPEN
2.080
PREV CLOSE
2.060
HIGH
2.110
LOW
2.040
VOLUME
161.47K
TURNOVER
--
52 WEEK HIGH
4.850
52 WEEK LOW
1.560
MARKET CAP
100.58M
P/E (TTM)
-3.5117
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Allscripts Healthcare Solutions Shares Jump
Toward the end of trading Wednesday, the Dow traded down 0.45% to 28550.31 while the NASDAQ fell 0.75% to 11775.45. The S&P also fell, dropping 0.56% to 3,492.39.
Benzinga · 10/14 18:33
NIO, MDRX, SRNE and DVAX among midday movers
Gainers: Interpace Biosciences (IDXG) +41%.Allscripts Healthcare Solutions (MDRX) +31%.Replimune Group (REPL) +27%.VOXX International (VOXX) +25%.AnaptysBio (ANAB) +22%.NIO (NIO) +20%.OncoCyte (OCX) +20%.Panhandle Oil and Gas (PHX) +16%.RealNetworks (RNWK) +14%.Oblong (OBLG) +13%.Losers: Cyclerion Therapeutics
Seekingalpha · 10/14 16:38
Mid-Day Market Update: Crude Oil Rises 1.5%; Cyclerion Therapeutics Shares Plummet
Midway through trading Wednesday, the Dow traded up 0.01% to 28683.10 while the NASDAQ rose 0.11% to 11,876.67. The S&P also rose, gaining 0.06% to 3,514.04.
Benzinga · 10/14 16:13
Interpace Biosciences, AnaptysBio leads healthcare gainers, Cyclerion Therapeutics, Enzo Biochem among major losers
Gainers: Interpace Biosciences (IDXG) +42%, AnaptysBio (ANAB) +32%, Replimune Group (REPL) +31%, Allscripts Healthcare Solutions (MDRX) +29%, OncoCyte (OCX) +19%.Losers: Cyclerion Therapeutics (CYCN) -47%, Enzo Biochem (ENZ) -17%, Sorrento Therapeutics (SRNE) -14%, Aethlon Medical (AEMD) -14%, Celldex Therapeutics (CLDX) -8%.
Seekingalpha · 10/14 14:59
Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Tops Q3 Expectations
Following the market opening Wednesday, the Dow traded up 0.25% to 28751.55 while the NASDAQ rose 0.28% to 11,897.16. The S&P also rose, gaining 0.25% to 3,520.75.
Benzinga · 10/14 14:14
The Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochem's Q4, Codiak Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 13)
Benzinga · 10/14 11:53
MDRX, VOXX, ENZ and FLWS among after-hours movers
Gainers: [[MDRX]] +49.2%. [[VOXX]] +18.1%. [[BBBY]] +6.2%. [[FUBO]] +5.6%. [[GME]] +5.6%.Losers: [[ENZ]] -10.7%. [[ATEC]] -9.2%. [[OCUL]] -9.2%. [[PNTG]] -6.1%. [[FLWS]] -4.7%.
Seekingalpha · 10/13 21:42
10 Stocks Moving In Tuesday's After-Hours Session
Gainers Bed Bath & Beyond (NASDAQ: BBBY) shares are trading higher after the company announced it plans to sell its non-core assets.
Benzinga · 10/13 21:21
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ENZ. Analyze the recent business situations of Enzo Biochem through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ENZ stock price target is 5.50 with a high estimate of 5.50 and a low estimate of 5.50.
EPS
Institutional Holdings
Institutions: 122
Institutional Holdings: 30.92M
% Owned: 64.55%
Shares Outstanding: 47.90M
TypeInstitutionsShares
Increased
26
876.82K
New
19
1.20M
Decreased
20
2.29M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+1.09%
Healthcare Providers & Services
+1.38%
Key Executives
President/Director
Barry Weiner
Chief Executive Officer/Chairman/Director/Secretary
Elazar Rabbani
Chief Financial Officer
David Bench
Vice President/Director of Sales/Director of Marketing
Bruce Dey
Vice President
Kara Cannon
Other
Dieter Schapfel
Lead Director/Independent Director
Dov Perlysky
Director
Fabian Blank
Director
Peter Clemens
Independent Director
Rebecca Fischer
Independent Director
Bruce Hanna
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ENZ
Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company's segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. It offers a menu of molecular and other clinical laboratory tests or procedures. Enzo Life Sciences manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers. Enzo Therapeutics is a biopharmaceutical venture that develops multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases. Its products in the development pipeline include a range of assays for detection of various women's health infectious agents, as well as for use in the identification of pathogens for other markets.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Enzo Biochem, Inc. stock information, including NYSE:ENZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENZ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ENZ stock methods without spending real money on the virtual paper trading platform.